August 17, 2026

AptarGroup, Inc. (ATR) Investor Outlook: Potential 28.8% Upside Sparks Interest

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a compelling potential upside of 28.8%...

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring the 15.87% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $9.83 billion, this U.S.-based company is making..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Sleep Apnea Market with a 5.78% Upside Potential

Inspire Medical Systems, Inc. (INSP) is a key player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, the company has been at the..

Guardant Health, Inc. (GH) Stock Analysis: A 23.59% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, a field that is gaining significant traction as technological advancements continue to redefine cancer diagnostics and..

FTSE 100 gains support from miners, AstraZeneca and Rolls-Royce

Miners, AstraZeneca and Rolls-Royce supported the FTSE 100 as markets prepared for UK employment and inflation data that could influence interest-rate expectations...

The Ensign Group, Inc. (ENSG) Investor Outlook: Analyzing 21.11% Potential Upside Amid Healthcare Expansion

The Ensign Group, Inc. (NASDAQ: ENSG), a leader in the healthcare sector, primarily operating within the medical care facilities industry, presents a compelling opportunity for investors seeking growth combined with..

United Therapeutics Corporation (UTHR) Stock Analysis: Potential 30% Upside Captivates Investors

United Therapeutics Corporation (NASDAQ: UTHR) is currently capturing the attention of individual investors with a promising potential upside of 30.72%. Operating in the healthcare sector, United Therapeutics specializes in developing..

Bruker Corporation (BRKR) Stock Analysis: A Close Look at Its 1.82% Potential Upside Amidst Healthcare Sector Dynamics

As the healthcare sector continues to evolve with groundbreaking innovations, Bruker Corporation (NASDAQ: BRKR) stands out as a pivotal player within the medical devices industry. With a market capitalization of..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with 141.76% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a significant player in the biotechnology sector, attracting attention with its innovative approach to cell therapies, particularly in oncology. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: Evaluating Growth Potential with a 7.79% Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing investment opportunity for those eyeing growth and stability...

Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the healthcare plans industry, has caught the attention of investors with its robust market presence and promising growth metrics. With a market..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling an 18% Potential Upside amid Robust Revenue Growth

Corcept Therapeutics Incorporated (NASDAQ: CORT), a noteworthy player in the biotechnology industry, is capturing investor attention with its promising growth metrics and significant upside potential. With a market capitalization of..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling Growth Potential with a 9.84% Upside

TransMedics Group, Inc. (TMDX) stands as a pioneering force in the healthcare sector, specifically within the medical devices industry. This U.S.-based company has carved a niche for itself through its..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a Volatile Journey in TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based firm specializing in Traditional Chinese Medicine (TCM), presents a unique investment opportunity within the healthcare sector. Despite the lack of a..

RadNet, Inc. (RDNT) Stock Analysis: A 21.64% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Los Angeles, California, RadNet has carved a niche..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a Potential 43% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. Founded in 1993 and headquartered in Morrisville, North Carolina,..

Glaukos Corporation (GKOS) Stock Analysis: Assessing Growth Potential Amid a Robust Revenue Surge

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its significant market presence and promising growth trajectory...

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Glimpse into the 14.86% Potential Upside

Investors keeping an eye on the healthcare sector might want to delve deeper into Jazz Pharmaceuticals plc (NASDAQ: JAZZ). With a market capitalization of $15.9 billion, this Dublin-based biotech entity..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 19.47% Potential Upside with Robust Revenue Growth

CVS Health Corporation (NYSE: CVS), a heavyweight in the healthcare sector, is capturing investor attention with a compelling proposition of a 19.47% potential upside according to recent analyst ratings. With..

Nuvalent, Inc. (NUVL) Stock Analysis: Steady at $123.96 with Phase 2 Clinical Trials on the Horizon

For investors focused on the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a unique profile as a clinical-stage biopharmaceutical company targeting breakthrough therapies for cancer patients. With a market capitalization..

Search

Funds

August 17, 2026

FTSE 100 gains support from miners, AstraZeneca and Rolls-Royce

Miners, AstraZeneca and Rolls-Royce supported the FTSE 100 as markets prepared for UK employment and inflation data that could influence interest-rate expectations...
Search

Funds

August 17, 2026

FTSE 100

Funds